Prelude Therapeutics, Inc. (PRLD)
2.10
+0.28
(+15.38%)
USD |
NASDAQ |
Jan 22, 13:38
Prelude Therapeutics Market Cap: 132.02M for Jan. 22, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Incyte Corp. | 20.65B |
| BioLife Solutions, Inc. | 1.248B |
| Protalix Biotherapeutics, Inc. | 168.08M |
| Aclaris Therapeutics, Inc. | 498.39M |
| Relay Therapeutics, Inc. | 1.333B |
Market Cap Related Metrics
| PS Ratio | 14.16 |
| Price to Book Value | 2.255 |
| Price | 2.10 |
| Earnings Yield | -76.82% |